Demonstrates bariatric surgery plus medical therapy reduces hyperglycemia over 5 years in type 2 diabetes with BMI 27–43, highlighting durable surgical benefits.
Five-year outcome data showed that, among patients with type 2 diabetes and a BMI of 27 to 43, bariatric surgery plus intensive medical therapy was more effective than intensive medical therapy alone in decreasing, or in some cases resolving, hyperglycemia. (Funded by Ethicon Endo-Surgery and others; STAMPEDE ClinicalTrials.gov number, NCT00432809 .).
No takes yet. Share an insight, caveat, or question.
Schauer et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: